Global Medical Imaging Reagents Market 2017-2021

  • ID: 4420449
  • Report
  • Region: Global
  • 95 pages
  • TechNavio
1 of 5

FEATURED COMPANIES

  • Bayer
  • Bracco Diagnostics
  • Cardinal Health
  • Curium
  • DONGKOOK
  • Eli Lilly and Company
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

About Medical Imaging Reagents

Medical imaging reagents are substances that are designed to enhance the imaging of specific organs, tissues, diseases, and physiological functions using medical imaging equipment to diagnose and monitor diseases. Medical imaging reagents are used in a wide range of imaging modalities such as X-ray, computed tomography (CT), ultrasound, single photon emission computed tomography (SPECT), positron emission tomography (PET), and magnetic resonance imaging (MRI). Imaging reagents have improved the quality of medical imaging examinations.

The analysts forecast the global medical imaging reagents market to grow at a CAGR of 8.57% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global medical imaging reagents market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Medical Imaging Reagents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Bayer
  • Bracco Diagnostics
  • GE Healthcare
  • Guerbet Group
  • Lantheus Medical Imaging
Other prominent vendors
  • Cardinal Health
  • Curium
  • DONGKOOK
  • Eli Lilly and Company
  • Isologic Innovative Radiopharmaceuticals
  • Jiangsu Hengrui Medicine
  • Piramal Imaging
  • SHINE Medical Technologies
Market drivers
  • Rising incidence of cardiovascular disorders and cancer
  • For a full, detailed list, view the full report
Market challenges
  • High cost of developing imaging reagents
  • For a full, detailed list, view the full report
Market trends
  • Increasing number of strategic collaborations
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bayer
  • Bracco Diagnostics
  • Cardinal Health
  • Curium
  • DONGKOOK
  • Eli Lilly and Company
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Overview
PART 05: Market landscape
  • Overview
  • Market size and forecast
  • Five forces analysis
PART 06: Segmentation by product type
  • Overview
  • Contrast reagents
  • Nuclear imaging reagents
PART 07: Segmentation by geography
  • Overview
  • Americas
  • EMEA
  • APAC
PART 08: Decision framework

PART 09: Drivers and challenges
  • Market drivers
  • Market challenges
PART 10: Market trends
  • Increasing number of strategic collaborations
  • Increasing number of product approvals
  • Increasing R&D focus on nanotechnology-based imaging reagents
PART 11: Vendor landscape
  • Competitive landscape
PART 12: Key vendor analysis
  • Bayer
  • Bracco Diagnostics
  • GE Healthcare
  • Guerbet Group
  • Lantheus Medical Imaging
  • Other prominent vendors
PART 13: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Global medical imaging reagents market: Segmentation
Exhibit 02: Global medical imaging reagents market 2016-2021 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global medical imaging reagents market: Segmentation by product type 2016 (% share)
Exhibit 05: Global contrast reagents market 2016-2021 ($ millions)
Exhibit 06: Global contrast reagents market: Segmentation by product type 2016 (% share)
Exhibit 07: Major iodinated contrast reagents
Exhibit 08: Global Iodinated contrast reagents market 2016-2021($ millions)
Exhibit 09: Major gadolinium contrast reagents
Exhibit 10: Global gadolinium contrast reagents market 2016-2021 ($ millions)
Exhibit 11: Major microbubbles contrast reagents
Exhibit 12: Global microbubbles contrast reagents market 2016-2021 ($ millions)
Exhibit 13: Global barium-based contrast reagents market 2016-2021 ($ millions)
Exhibit 14: Major nuclear imaging reagents
Exhibit 15: Global nuclear imaging reagents market 2016-2021 ($ millions)
Exhibit 16: Global medical imaging reagents market: Segmentation by geography 2016 (% share)
Exhibit 17: Medical imaging reagents market in Americas 2016-2021 ($ millions)
Exhibit 18: Medical imaging reagents market in EMEA 2016-2021 ($ millions)
Exhibit 19: Medical imaging reagents market in APAC 2016-2021 ($ millions)
Exhibit 20: Number of MRI exams performed by hospitals and ASCs per 1,000 people 2013-2015
Exhibit 21: Number of CT exams performed by hospitals and ASCs per 1,000 people 2013-2015
Exhibit 22: Global medical imaging reagents market: Competitive structure analysis 2016
Exhibit 23: Bayer: Key highlights
Exhibit 24: Bayer: Strength assessment
Exhibit 25: Bayer: Strategy assessment
Exhibit 26: Bayer: Opportunity assessment
Exhibit 27: Bracco Diagnostics: Key highlights
Exhibit 28: Bracco Diagnostics: Strength assessment
Exhibit 29: Bracco Diagnostics: Strategy assessment
Exhibit 30: Bracco Diagnostics: Opportunity assessment
Exhibit 31: GE Healthcare: Key highlights
Exhibit 32: GE Healthcare: Strength assessment
Exhibit 33: GE Healthcare: Strategy assessment
Exhibit 34: GE Healthcare: Opportunity assessment
Exhibit 35: Guerbet Group: Key highlights
Exhibit 36: Guerbet Group: Strength assessment
Exhibit 37: Guerbet Group: Strategy assessment
Exhibit 38: Guerbet Group: Opportunity assessment
Exhibit 39: Lantheus Medical Imaging: Key highlights
Exhibit 40: Lantheus Medical Imaging: Strength assessment
Exhibit 41: Lantheus Medical Imaging: Strategy assessment
Exhibit 42: Lantheus Medical Imaging: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Bayer
  • Bracco Diagnostics
  • Cardinal Health
  • Curium
  • DONGKOOK
  • Eli Lilly and Company
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

New Report Released: – Global Medical Imaging Reagents Market 2017-2021

The author of the report recognizes the following companies as the key players in the global medical imaging reagents market: Bayer, Bracco Diagnostics, GE Healthcare, Guerbet Group, and Lantheus Medical Imaging.

Other Prominent Vendors in the market are: Cardinal Health, Curium, DONGKOOK, Eli Lilly and Company, Isologic Innovative Radiopharmaceuticals, Jiangsu Hengrui Medicine, Piramal Imaging, and SHINE Medical Technologies.

Commenting on the report, an analyst from the research team said: “One trend in the market is increasing number of strategic collaborations. Strategic collaborations are becoming common in the global medical imaging reagents market. Many vendors are engaging in strategic collaborations to enhance their product development capabilities and strengthen their market position.”

According to the report, one driver in the market is rising incidence of cardiovascular disorders and cancer. The global incidence of CVDs such as angina, myocardial infarction, stroke, heart failure, venous thromboembolism, heart arrhythmia, and their associated risk factors are increasing. CVDs are estimated to cause approximately 19 million deaths across the world by 2020. In 2013, nearly 1.9 million people died due to CVD in the European Union (EU). According to the Centers for Disease Control and Prevention (CDC), in the US, approximately 610,000 people die from heart disease every year. Annually, about 735,000 people in the US have a heart attack.

Further, the report states that one challenge in the market is high cost of developing imaging reagents. The average time taken to develop diagnostic drugs is approximately 10 years. It costs $150 million. The sales of imaging agent can range between $100 million and $500 million. The time taken to develop a therapeutic drug is around 15 years. It costs between $800 million and $900 million. However, therapeutic drugs can generate sales of nearly $3.5 billion. Therefore, the return on investment from the commercialization of imaging agents is significant when compared with therapeutic drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

  • Bayer
  • Bracco Diagnostics
  • GE Healthcare
  • Guerbet Group
  • Lantheus Medical Imaging
  • Cardinal Health
  • Curium
  • DONGKOOK
  • Eli Lilly and Company
  • Isologic Innovative Radiopharmaceuticals
  • Jiangsu Hengrui Medicine
  • Piramal Imaging
  • SHINE Medical Technologies
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll